New hemophilia drug enters human safety trials
Disease control
Recruiting now
This early-stage study tests a new drug called SR604 in healthy people and those with hemophilia A, B, or factor VII deficiency. The main goal is to check safety and how the drug moves through the body. About 31 participants will receive single or multiple doses to find the right…
Phase: PHASE1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC